Abstract
Pyrrolidon carboxypeptidase is an omega-peptidase that hydrolyses N-terminal pyroglutamyl
residues from biologically active peptides such as gonadotropin-releasing and thyrotrophin-releasing
hormones. We previously described a decrease in both rat and human pyrrolidon carboxypeptidase
activity with breast cancer, suggesting that gonadotropin-releasing hormone may be
an important local intracrine, autocrine and/or paracrine hormonal factor in the pathogenesis
of breast cancer while playing a role in the tumoral process. However, the other susceptible
substrate of pyrrolidon carboxypeptidase, thyrotrophin-releasing hormone, may also
be modified with breast cancer, supporting an association between breast cancer and
thyroid disorders. The present work analyses soluble and membrane-bound pyrrolidon
carboxypeptidase activities in the hypothalamus-pituitary-thyroid and hypothalamus-pituitary-ovary
axes in N-methyl nitrosourea-induced breast cancer in rats. Our aim was to determine
the possible relationship between gonadotropin-releasing hormone and thyrotrophin-releasing
hormone regulation through pyrrolidon carboxypeptidase activity. We propose that pyrrolidon
carboxypeptidase activity dysregulation at various local and systemic levels may participate
in the initiation, promotion and progression of breast cancer induced in rat by N-methyl
nitrosourea through the increase in gonadotropin-releasing hormone. Since pyrrolidon
carboxypeptidase activity also acts on thyrotrophin-releasing hormone, the dysregulation
of this enzyme’s activity could indirectly affect hypothalamus-pituitary-thyroid axis
function, and thus potentially represent a link between the diseases of thyroid and
breast cancer.
Key words
Pyroglutamyl aminopeptidase · Breast cancer · GnRH · TRH · Hypothalamus-pituitary-thyroid
axis · Hypothalamus-pituitary-ovary axis
References
1
Cummins P M, O’Connor B.
Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
Biochim Biophys Acta.
1998;
1429
1-17
2 McDonald J K, Barret A. Mammalian Proteases: A Glossary and Bibliography. Exopeptidase.
London; Academic Press 1986
3
Browne P, O’Cuinn G.
An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme
and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction
of guinea-pig brain, in the degradation of thyroliberin in vitro.
Eur J Biochem. .
1983;
137
75-87
4
O’Connor B, O’Cuinn G.
Localization of a narrow-specificity thyroliberin hydrolyzing pyroglutamate aminopeptidase
in synaptosomal membranes of guinea-pig brain.
Eur J Biochem.
1984;
144
271-278
5
Bauer K.
Purification and characterization of the thyrotropin-releasing-hormone-degrading ectoenzyme.
Eur J Biochem.
1994;
224
387-396
6
Russo J, Russo I H.
Atlas and histologic classification of tumors of the rat mammary gland.
J Mammary Gland Biol Neoplasia.
2000;
5
187-200
7
Carrera M P, Ramirez-Exposito M J, Valenzuela M T, Garcia M J, Mayas M D, Martinez-Martos J M.
Serum pyrrolidone carboxypeptidase activity in N-methyl-nitrosourea induced rat breast
cancer.
Horm Metab Res.
2003;
35
502-505
8
Martínez J M, Prieto I, Ramírez M J, Cueva C, Alba F, Ramírez M.
Aminopeptidase activities in breast cancer tissue.
Clin Chem.
1999;
45
1797-1802
9
Kottler M L, Starzec A, Carre M C, Lagarde J P, Martin A, Counis R.
The genes for gonadotropin-releasing hormone and its receptor are expressed in human
breast with fibrocystic disease and cancer.
Int J Cancer.
1997;
71
595-599
10
Goldman M B.
Thyroid diseases and breast cancer.
Epidemiol Rev.
1990;
12
16-28
11
Hoffman D A, McConahey W M, Brinton L A, Fraumeni J F Jr.
Breast cancer in hypothyroid women using thyroid supplements.
JAMA.
1984;
251
616-619
12
Ito K, Maruchi N.
Breast cancer in patients with Hashimoto’s thyroiditis.
Lancet.
1975;
2
1119-1121
13
Morabia A, Szklo M, Stewart W, Schuman L, Thomas D B, Zacur H A.
Thyroid hormones and duration of ovulatory activity in the etiology of breast cancer.
Cancer Epidemiol Biomarkers Prev.
1992;
1
389-393
14
Shering S G, Zbar A P, Moriarty M, McDermott E W, O’Higgins N J, Smith P P.
Thyroid disorders and breast cancer.
Eur J Cancer Prev.
1996;
5
504-506
15
Vassilopoulou-Sellin R, Palmer L, Taylor S, Cooksley C S.
Incidence of breast carcinoma in women with thyroid carcinoma.
Cancer.
1999;
85
696-705
16
Silva J M, Dominguez G, Gonzalez-Sancho J M, Garcia J M, Silva J, Garcia-Andrade C,
Navarro A, Muñoz A, Bonilla F.
Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.
Oncogene.
2002;
21
4307-4316
17
Smyth P P, Shering S G, Kilbane M T, Murray M J, McDermott E W, Smith D F, O’Higgins N J.
Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma.
J Clin Endocrinol Metab.
1998;
83
2711-2716
18
Rivera E S, Andrade N, Martin G, Melito G, Cricco G, Mohamad N, Davio C, Caro R, Bergoc R N.
Induction of mammary tumors in rat by intraperitoneal inyection of NMU; histopathology
and estral cycle influence.
Cancer Lett.
1994;
86
223-228
19
Ramirez-Exposito M J, Garcia M J, Mayas M D, Carrera M P, Tsuboyama G, Martinez-Martos J M.
Effects of dietary cholesterol on pyroglutamyl aminopeptidase activity in mouse frontal
cortex, pituitary, and adrenal glands.
Horm Metab Res.
2002;
34
431-434
20
Smyth P P.
The thyroid, iodine and breast cancer.
Breast Cancer Res.
2003;
5
235-238
21
Mittra I, Perrin J, Kumaoka S.
Thyroid and other autoantibodies in British and Japanese women: an epidemiological
study of breast cancer.
Br Med J.
1976;
1(6004)
257-259
22
Maruchi N, Annegers J F, Kurland L T.
Hashimoto’s thyroiditis and breast cancer.
Mayo Clin Proc.
1976;
511
263-265
23
Topper Y J, Sankaran L, Chomczynski P, Prosser C, Qasba P.
Three stages of responsiveness to hormones in the mammary cell.
Ann N Y Acad Sci.
1986;
464
1-10
24
Seeger H, Huober J, Wallwiener D, Mueck A O.
Inhibition of human breast cancer cell proliferation with estradiol metabolites is
as effective as with tamoxifen.
Horm Metab Res.
2004;
36
277-280
25
Koda M, Sulkowski S, Garofalo C, Kanczuga-Koda L, Sulkowska M, Surmcz E.
Expression of the insulin-like growth factor I receptor in primary breast cancer lymph
node metastases: correlations with estrogen receptors alfa and beta.
Horm Metab Res.
2003;
35
794-801
26
Abramovitch S, Werner H.
Functional and physical interactions between BRCA1 and p53 in transcriptional regulation
of the IGF-IR gene.
Horm Metab Res.
2003;
35
758-762
27
Russo J, Hu Y F, Yang X, Russo I H.
Developmental, cellular, and molecular basis of human breast cancer.
J Natl Cancer Inst Monogr.
2000;
27
17-37
28
Marshall J C, Kelch R P.
Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction.
N Engl J Med.
1986;
315
1459-1468
29 Reichlin S, Martin J B, Jackson I MD. In: Jeffcoate SL, Hutchinson JSM (eds) The
Endocrine Hypothalamus. New York; Academic Press 1978: 229-269
30
Awade A C, Cleuziat P, Gonzales T, Robert-Baudouy J.
Pyrrolidone carboxyl peptidase (Pcp): an enzyme that removes pyroglutamic acid (pGlu)
from pGlu-peptides and pGlu-proteins.
Proteins.
1994;
20
34-51
31
Huirne J A, Lambalk C.
Gonadotropin-releasing-hormone-receptor antagonists.
Lancet.
2001;
358
1793-1803
32
Vanderpump M P, Tunbridge W M, French J M, Appleton D, Bates D, Clark F, Grimley Evans J,
Hasan D M, Rodgers H, Tunbridge F. et al .
The incidence of thyroid disorders in the community: a twenty-year follow-up of the
Whickham Survey.
Clin Endocrinol (Oxf).
1995;
43
55-68
33
Stoll B A.
Breast cancer and hypothyroidism.
Cancer.
1965;
18
1431-1436
34
Takatani O, Okumoto T, Kosano H, Nishida M, Hiraide H, Tamakuma S.
Relationship between the levels of serum thyroid hormones or estrogen status and the
risk of breast cancer genesis in Japanese women.
Cancer Res.
1989;
49
3109-3112
35
Schomburg L, Bauer K.
Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the
thyrotropin-releasing hormone (TRH) receptor and the TRH-degrading ectoenzyme.
Endocrinology.
1995;
136
3480-3485
36
Hsieh K P, Martin T F.
Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate
phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and
G11.
Mol Endocrinol.
1992;
6
1673-1681
37
Aragay A M, Katz A, Simon M I.
The G alpha q and G alpha 11 proteins couple the thyrotropin-releasing hormone receptor
to phospholipase C in GH3 rat pituitary cells.
J Biol Chem.
1992;
267
24 983-24 988.
38
Kaiser U B, Conn P M, Chin W W.
Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing
pituitary cell lines.
Endocr Rev.
1997;
18
46-70
Dr. J. M. Martínez Martos
Área de Fisiología, Facultad de Ciencias Experimentales y de la Salud, Universidad
de Jaén
Campus Universitario ‘Las Lagunillas’ · 23071 Jaén · España
Phone: +34(953)212600 ·
Fax: +34(953)212141
Email: jmmartos@ujaen.es